This table shows the serotypes covered by the current pneumococcal conjugate vaccine products and the three additional products that are in the development pipeline.
-
Results & Summaries
-
Results & Summaries
This table provides a summary of studies on the duration of protection of COVID-19 vaccines. This table is updated weekly.
-
Briefs
In partnership with the Asian Development Bank, IVAC developed factsheets summarizing key measures for COVID-19 vaccines such as effectiveness and protection against severe disease.
-
Briefs
In partnership with the Asian Development Bank, IVAC developed factsheets summarizing key measures for COVID-19 vaccines such as effectiveness and protection against severe disease.
-
VIEW-Hub Reports
The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Hib, and inactivated polio vaccines both globally and in the 54 Gavi countries.
-
Briefs
In partnership with the Asian Development Bank, IVAC developed factsheets summarizing key measures for COVID-19 vaccines such as effectiveness and protection against severe disease.
-
Methods
This document outlines the methods used in the COVID-19 vaccines neutralization and cellular immunity studies review.
-
VIEW-Hub Reports
The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Hib, and inactivated polio vaccines both globally and in the 73 Gavi countries.
-
Results & Summaries
This table summarizes vaccine impact results for COVID-19 studies conducted globally. This table is updated weekly.
-
Results & Summaries
These forest plots summarize available COVID-19 vaccine effectiveness against Delta and Omicron variants by vaccine, disease outcome, and study population.